So I wonder what happens...NIH spends $30 Billion a year about...
NIH take a major stake in the game and have "some" control in allowing PS Targeting for all
I am sure some agreement could be made but the damage is done, many already accepted monies to stop their PS Targeting advances ..
Remember Dr Jedd Wolchok saying something like " we are waiting on the go ahead from the company"
Maybe Merck wanted to deal with Oncologie Inc or maybe all shareholders will soon realize this has NEVER been about a pure play CDMO
It was about shifting exosomes to MD Anderson
It was about not disrupting the Big Pharma Mafiacartel of profits
There is one problem though, flipped PS is on EVERY stressed cell and many a biomarker depend on it ...many blood tests will depend on it, that want to measure the type and stage of the cancer...YEARS in advance
Let me guess, John Springs Stafford had no idea...lol